FI20075861A0 - Enteroviruksen käyttö taudin diagnostiikassa, hoidossa ja ehkäisyssä - Google Patents

Enteroviruksen käyttö taudin diagnostiikassa, hoidossa ja ehkäisyssä

Info

Publication number
FI20075861A0
FI20075861A0 FI20075861A FI20075861A FI20075861A0 FI 20075861 A0 FI20075861 A0 FI 20075861A0 FI 20075861 A FI20075861 A FI 20075861A FI 20075861 A FI20075861 A FI 20075861A FI 20075861 A0 FI20075861 A0 FI 20075861A0
Authority
FI
Finland
Prior art keywords
enterovirus
diagnosis
disease
prevention
treatment
Prior art date
Application number
FI20075861A
Other languages
English (en)
Swedish (sv)
Inventor
Heikki Hyoety
Sisko Tauriainen
Sami Oikarinen
Maarit Oikarinen
Markku Maeki
Katri Kaukinen
Teemu Honkanen
Immo Rantala
Original Assignee
Vactech Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vactech Oy filed Critical Vactech Oy
Priority to FI20075861A priority Critical patent/FI20075861A0/fi
Publication of FI20075861A0 publication Critical patent/FI20075861A0/fi
Priority to CA2706415A priority patent/CA2706415A1/en
Priority to PCT/FI2008/050698 priority patent/WO2009068753A1/en
Priority to EP08854121.4A priority patent/EP2225366B1/en
Priority to AU2008328657A priority patent/AU2008328657A1/en
Priority to RU2010126629/10A priority patent/RU2010126629A/ru
Priority to US12/743,903 priority patent/US20110002943A1/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32311—Enterovirus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32311—Enterovirus
    • C12N2770/32332—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32311—Enterovirus
    • C12N2770/32334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/02—Nutritional disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/06—Gastro-intestinal diseases
FI20075861A 2007-11-30 2007-11-30 Enteroviruksen käyttö taudin diagnostiikassa, hoidossa ja ehkäisyssä FI20075861A0 (fi)

Priority Applications (7)

Application Number Priority Date Filing Date Title
FI20075861A FI20075861A0 (fi) 2007-11-30 2007-11-30 Enteroviruksen käyttö taudin diagnostiikassa, hoidossa ja ehkäisyssä
CA2706415A CA2706415A1 (en) 2007-11-30 2008-11-28 Use of enterovirus for diagnostics, treatment and prevention of disease
PCT/FI2008/050698 WO2009068753A1 (en) 2007-11-30 2008-11-28 Use of enterovirus for diagnostics, treatment and prevention of disease
EP08854121.4A EP2225366B1 (en) 2007-11-30 2008-11-28 Use of enterovirus for diagnostics, treatment and prevention of celiac disease
AU2008328657A AU2008328657A1 (en) 2007-11-30 2008-11-28 Use of enterovirus for diagnostics, treatment and prevention of disease
RU2010126629/10A RU2010126629A (ru) 2007-11-30 2008-11-28 Применение энтеровирусов для диагностики, лечения и профилактики
US12/743,903 US20110002943A1 (en) 2007-11-30 2008-11-28 Use of enterovirus for diagnostics, treatment and prevention of disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20075861A FI20075861A0 (fi) 2007-11-30 2007-11-30 Enteroviruksen käyttö taudin diagnostiikassa, hoidossa ja ehkäisyssä

Publications (1)

Publication Number Publication Date
FI20075861A0 true FI20075861A0 (fi) 2007-11-30

Family

ID=38786790

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20075861A FI20075861A0 (fi) 2007-11-30 2007-11-30 Enteroviruksen käyttö taudin diagnostiikassa, hoidossa ja ehkäisyssä

Country Status (7)

Country Link
US (1) US20110002943A1 (fi)
EP (1) EP2225366B1 (fi)
AU (1) AU2008328657A1 (fi)
CA (1) CA2706415A1 (fi)
FI (1) FI20075861A0 (fi)
RU (1) RU2010126629A (fi)
WO (1) WO2009068753A1 (fi)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20095592A0 (fi) * 2009-05-28 2009-05-28 Matti Waris Pikornavirusten differentiointi, nukleiinihappoja siihen, niiden käyttö ja niitä käyttävät biomääritysmenetelmät
DE102009034553A1 (de) * 2009-07-23 2011-01-27 Oerter, Detlef, Dr. Impfstoff zur Prävention von akuter lymphoblastischer Leukämie bei Kindern

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001000236A1 (en) 1999-06-24 2001-01-04 Hyoety Heikki Prevention of type 1 diabetes and other non-polio enterovirus diseases

Also Published As

Publication number Publication date
EP2225366A4 (en) 2011-02-16
EP2225366B1 (en) 2015-04-22
RU2010126629A (ru) 2012-01-10
WO2009068753A1 (en) 2009-06-04
EP2225366A1 (en) 2010-09-08
CA2706415A1 (en) 2009-06-04
AU2008328657A1 (en) 2009-06-04
US20110002943A1 (en) 2011-01-06

Similar Documents

Publication Publication Date Title
HK1158705A1 (zh) 微泡在醫學疾病和病況的診斷、預後以及治療中的用途
BRPI0813212A2 (pt) Métodos de tratamento de doenças e distúrbios mediados por serotonina
NO20081842L (no) Fremgangsmåter og sammensetninger for anvendelse ved behandling av pasienter med autoantistoff-positive sykdommer
DK2609855T3 (da) Balanceret fysiologisk overvågnings- og behandlingssystem
BRPI0919288A2 (pt) teriapia de combinação para tratamento de diabetes e condições relacionadas.
DK2049525T3 (da) N-laminoheteroaryl)-1H-indol-2-carboxamid-derivater, og fremstilling og terapeutisk anvendelse deraf
BRPI0917567A2 (pt) tratamento de doença respiratória
BRPI0811845A2 (pt) Forma de dosagem, e, métodos de preparação da forma de dosagem, e de tratamento de uma má condição em um paciente
BRPI0815551A2 (pt) Tratamento através de hucbc de doença beta-amiloide
BRPI0907624A2 (pt) tratamento e prevenção de doenças cardíacas usando duas ou mais isoformas do fator de crescimento de hepatócito
HK1155167A1 (en) Phenoxypyridinylamide derivatives and their use in the treatment of pde4 mediated disease states pde4
BRPI1008517A2 (pt) direcionamento duplo de mir-208 e mir-499 no tratamento de doenças cardíacas.
GB0608647D0 (en) Methods of diagnosis and treatment
HK1147991A1 (en) Substituted (oxazolidinon-5-yl-methyl) -2-thiophene-carboxamides and use thereof in the field of blood coagulation
EP2220208A4 (en) USE OF HAPTOGLOBIN GENOTYPING IN THE DIAGNOSIS AND TREATMENT OF CARDIOVASCULAR DISEASE
BRPI0909563A2 (pt) biomaterial, método de produção do biomaterial, uso do biomaterial e mpetodo de tratamento de lesões de tecidos em pacientes
DK2310383T3 (da) 2-oxo-alkyl-1-piperazin-2-onderivater, fremstilling deraf og terapeutisk anvendelse deraf
EP2061442A4 (en) TREATMENT, PREVENTION AND REVERSAL OF ALCOHOL-INDUCED BRAIN DISEASES
BRPI0810461A2 (pt) Combinação de drogas e seu uso no tratamento de perda muscular
DK2194968T3 (da) Lerbaseret, aromatiseret og terapeutisk sammensætning
FI20075861A0 (fi) Enteroviruksen käyttö taudin diagnostiikassa, hoidossa ja ehkäisyssä
GB0604779D0 (en) Treatment,diagnosis and imaging of disease
EP2190990A4 (en) PTHRP, its isoforms and antagonist for the diagnosis and treatment of diseases
FI20055564A0 (fi) Fysiologisten parametrien hankkiminen ja käsittely
IL205924A0 (en) Use of haptoglobin genotyping in diagnosis and treatment of cardiovascular disease

Legal Events

Date Code Title Description
FD Application lapsed